Grigoris Zoidis

1.2k total citations
57 papers, 961 citations indexed

About

Grigoris Zoidis is a scholar working on Epidemiology, Organic Chemistry and Molecular Biology. According to data from OpenAlex, Grigoris Zoidis has authored 57 papers receiving a total of 961 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Epidemiology, 21 papers in Organic Chemistry and 20 papers in Molecular Biology. Recurrent topics in Grigoris Zoidis's work include Hepatitis C virus research (16 papers), HIV/AIDS drug development and treatment (16 papers) and Hepatitis B Virus Studies (11 papers). Grigoris Zoidis is often cited by papers focused on Hepatitis C virus research (16 papers), HIV/AIDS drug development and treatment (16 papers) and Hepatitis B Virus Studies (11 papers). Grigoris Zoidis collaborates with scholars based in Greece, United Kingdom and United States. Grigoris Zoidis's co-authors include Nicolas Kolocouris, George Fytas, Erik De Clercq, Lieve Naesens, John M. Kelly, Christos Fytas, George B. Foscolos, John E. Tavis, Ioannis Papanastasiou and Johan Neyts and has published in prestigious journals such as SHILAP Revista de lepidopterología, International Journal of Molecular Sciences and Journal of Medicinal Chemistry.

In The Last Decade

Grigoris Zoidis

55 papers receiving 942 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Grigoris Zoidis Greece 17 498 303 300 129 116 57 961
K. Raja Reddy United States 17 472 0.9× 483 1.6× 161 0.5× 50 0.4× 219 1.9× 26 1.1k
John A. McCauley United States 19 725 1.5× 517 1.7× 217 0.7× 36 0.3× 237 2.0× 33 1.4k
Ashoke Sharon India 24 896 1.8× 492 1.6× 148 0.5× 25 0.2× 187 1.6× 104 1.5k
George Fytas Greece 17 628 1.3× 389 1.3× 336 1.1× 153 1.2× 80 0.7× 43 1.1k
Nicolas Kolocouris Greece 20 756 1.5× 443 1.5× 375 1.3× 201 1.6× 67 0.6× 49 1.3k
George B. Foscolos Greece 19 661 1.3× 401 1.3× 301 1.0× 172 1.3× 57 0.5× 39 1.1k
Denis R. St. Laurent United States 17 311 0.6× 216 0.7× 166 0.6× 24 0.2× 154 1.3× 27 768
J. E. MUNROE United States 15 323 0.6× 352 1.2× 167 0.6× 33 0.3× 68 0.6× 26 877
Argyrides Argyrou United States 19 151 0.3× 733 2.4× 154 0.5× 112 0.9× 297 2.6× 30 1.0k
Abdalla E. A. Hassan United States 14 207 0.4× 422 1.4× 94 0.3× 14 0.1× 108 0.9× 64 783

Countries citing papers authored by Grigoris Zoidis

Since Specialization
Citations

This map shows the geographic impact of Grigoris Zoidis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Grigoris Zoidis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Grigoris Zoidis more than expected).

Fields of papers citing papers by Grigoris Zoidis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Grigoris Zoidis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Grigoris Zoidis. The network helps show where Grigoris Zoidis may publish in the future.

Co-authorship network of co-authors of Grigoris Zoidis

This figure shows the co-authorship network connecting the top 25 collaborators of Grigoris Zoidis. A scholar is included among the top collaborators of Grigoris Zoidis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Grigoris Zoidis. Grigoris Zoidis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Walden, Helen, et al.. (2025). Discovery of N-Hydroxypyridinedione-Based Inhibitors of HBV RNase H: Design, Synthesis, and Extended SAR Studies. International Journal of Molecular Sciences. 26(20). 10239–10239.
2.
Wright, A.F., Maria Halabalaki, Grigoris Zoidis, et al.. (2025). Discovery and Characterization of Uracil Derivatives Targeting the Set-and-Ring Domain of UHRF1. Journal of Chemical Information and Modeling. 65(17). 9274–9286.
3.
Zoidis, Grigoris, et al.. (2025). A New Era of Muscarinic Acetylcholine Receptor Modulators in Neurological Diseases, Cancer and Drug Abuse. Pharmaceuticals. 18(3). 369–369. 2 indexed citations
4.
5.
Walden, Heather S., et al.. (2024). Efficacy and in vitro pharmacological assessment of novel N -hydroxypyridinediones as hepatitis B virus ribonuclease H inhibitors. Antimicrobial Agents and Chemotherapy. 69(1). e0145524–e0145524. 1 indexed citations
6.
Zoidis, Grigoris, et al.. (2023). Targeting Metalloenzymes: The “Achilles’ Heel” of Viruses and Parasites. Pharmaceuticals. 16(6). 901–901. 7 indexed citations
7.
Taylor, Martin C., et al.. (2023). Novel Lipophilic Hydroxamates Based on Spirocarbocyclic Hydantoin Scaffolds with Potent Antiviral and Trypanocidal Activity. Pharmaceuticals. 16(7). 1046–1046. 2 indexed citations
8.
Hamed, Mostafa M., Sotirios Katsamakas, Niki Vassilaki, et al.. (2022). Design and Synthesis of Novel Bis-Imidazolyl Phenyl Butadiyne Derivatives as HCV NS5A Inhibitors. Pharmaceuticals. 15(5). 632–632. 2 indexed citations
9.
Nasr, Tamer, et al.. (2022). Novel 6-Aminoquinazolinone Derivatives as Potential Cross GT1-4 HCV NS5B Inhibitors. Viruses. 14(12). 2767–2767. 4 indexed citations
10.
Schwedtmann, Kai, et al.. (2021). Design and Synthesis of Novel Symmetric Fluorene-2,7-Diamine Derivatives as Potent Hepatitis C Virus Inhibitors. Pharmaceuticals. 14(4). 292–292. 3 indexed citations
11.
Zoidis, Grigoris, Eftichia Kritsi, Marija Ivanov, et al.. (2020). The Triazole Ring as a Privileged Scaffold for Putative Antifungals: Synthesis and Evaluation of a Series of New Analogues. ChemMedChem. 16(1). 134–144. 15 indexed citations
12.
Zoidis, Grigoris, et al.. (2020). A multi-technique analytical approach for impurity profiling during synthesis: The case of difluprednate. Journal of Pharmaceutical and Biomedical Analysis. 190. 113483–113483. 2 indexed citations
13.
Vassilaki, Niki, et al.. (2019). Symmetric Anti-HCV Agents: Synthesis, Antiviral Properties, and Conformational Aspects of Core Scaffolds. ACS Omega. 4(7). 11440–11454. 5 indexed citations
14.
Vassilaki, Niki, et al.. (2018). Expanding the chemical space of anti‐HCV NS5A inhibitors by stereochemical exchange and peptidomimetic approaches. Archiv der Pharmazie. 351(7). e1800017–e1800017. 6 indexed citations
15.
Sosic, Alice, Odra Pinato, Grigoris Zoidis, et al.. (2016). Quinolino[3,4- b ]quinoxalines and pyridazino[4,3- c ]quinoline derivatives: Synthesis, inhibition of topoisomerase IIα, G-quadruplex binding and cytotoxic properties. European Journal of Medicinal Chemistry. 123. 704–717. 33 indexed citations
16.
Zoidis, Grigoris, Andrew Tsotinis, Nicolas Kolocouris, et al.. (2008). Design and synthesis of bioactive 1,2-annulated adamantane derivatives. Organic & Biomolecular Chemistry. 6(17). 3177–3177. 32 indexed citations
17.
Kolocouris, Nicolas, Grigoris Zoidis, George B. Foscolos, et al.. (2007). Design and synthesis of bioactive adamantane spiro heterocycles. Bioorganic & Medicinal Chemistry Letters. 17(15). 4358–4362. 84 indexed citations
18.
Zoidis, Grigoris, Christos Fytas, Ioannis Papanastasiou, et al.. (2006). Heterocyclic rimantadine analogues with antiviral activity. Bioorganic & Medicinal Chemistry. 14(10). 3341–3348. 109 indexed citations
19.
Zoidis, Grigoris, Ioannis Papanastasiou, Yannis Dotsikas, et al.. (2005). The novel GABA adamantane derivative (AdGABA): design, synthesis, and activity relationship with gabapentin. Bioorganic & Medicinal Chemistry. 13(8). 2791–2798. 37 indexed citations
20.
Kolocouris, Antonios, Kostas Dimas, Christophe Pannecouque, et al.. (2002). New 2-(1-adamantylcarbonyl)pyridine and 1-acetyladamantane thiosemicarbazones–thiocarbonohydrazones: cell growth inhibitory, antiviral and antimicrobial activity evaluation. Bioorganic & Medicinal Chemistry Letters. 12(5). 723–727. 55 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by K. Raja Reddy Breakdown of academic impact, for papers by John A. McCauley Breakdown of academic impact, for papers by Ashoke Sharon Breakdown of academic impact, for papers by George Fytas Breakdown of academic impact, for papers by Nicolas Kolocouris Breakdown of academic impact, for papers by George B. Foscolos Breakdown of academic impact, for papers by Denis R. St. Laurent Breakdown of academic impact, for papers by J. E. MUNROE Breakdown of academic impact, for papers by Argyrides Argyrou Breakdown of academic impact, for papers by Abdalla E. A. Hassan
Rankless by CCL
2026